These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 975418)

  • 21. Piromidic acid, a new antibacterial agent: antibacterial properties.
    Shimizu M; Nakamura S; Takase Y
    Antimicrob Agents Chemother (Bethesda); 1970; 10():117-22. PubMed ID: 4939730
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrido[2,3-d]pyrimidine antibacterial agents. IV. Synthesis of metabolites of piromidic acid.
    Matsumoto J; Minamida A; Kimura Y; Minami S
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2531-6. PubMed ID: 7428132
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of norfloxacin in renal failure.
    Fillastre JP; Hannedouche T; Leroy A; Humbert G
    J Antimicrob Chemother; 1984 Oct; 14(4):439. PubMed ID: 6238930
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood level measurements and antimicrobial agents.
    Kunin CM
    Clin Pharmacol Ther; 1974 Jul; 16(1):251-9. PubMed ID: 4367254
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-q uinoline- carboxylic acid (BAY Vp 2674) in chickens.
    Conzelman GM; Babish JG; Davidson JN; McMillan RA; Copeland DD
    Proc West Pharmacol Soc; 1987; 30():393-5. PubMed ID: 3628311
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pefloxacine: diffusion into bronchial mucus].
    Morel C; Vergnaud M; Langeard M; Benard Y
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):516-9. PubMed ID: 6589585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats.
    Naora K; Katagiri Y; Iwamoto K; Tanaka K; Yamaguchi T; Sekine Y
    J Antimicrob Chemother; 1992 Nov; 30(5):673-83. PubMed ID: 1337351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cinoxacin in patients with renal failure.
    Szwed JJ; Brannon DE; Sloan RS; Luft FC
    J Antimicrob Chemother; 1978 Sep; 4(5):451-4. PubMed ID: 690045
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of antibacterials in calves.
    Knifton A
    Vet Rec; 1982 Jul; 111(3):49-52. PubMed ID: 7123821
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of long half-life antibacterials.
    Follath F
    J Antimicrob Chemother; 1979 Nov; 5(B):97-102. PubMed ID: 536350
    [No Abstract]   [Full Text] [Related]  

  • 31. Research on antibacterial and antifungal agents. III. Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrryl)quinoline-3-carboxylic acid and of some 6-derivatives.
    Artico M; Corelli F; Massa S; Stefancich G; Panico S; Simonetti N
    Farmaco Sci; 1984 Nov; 39(11):910-24. PubMed ID: 6440810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3- quinoline- carboxylic acid (CFPQ) in turkeys.
    Conzelman GM; McMillan RA; Baggot JD
    Proc West Pharmacol Soc; 1986; 29():321-3. PubMed ID: 3763616
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous liquid chromatographic determination of residual synthetic antibacterials in cultured fish.
    Nose N; Hoshino Y; Kikuchi Y; Horie M; Saitoh K; Kawachi T; Nakazawa H
    J Assoc Off Anal Chem; 1987; 70(4):714-7. PubMed ID: 3624182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats.
    Yu IL; Chung SJ; Lee MH; Shim CK
    J Pharm Sci; 1997 May; 86(5):550-3. PubMed ID: 9145377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of tetroxoprim/sulphadiazine in patients with impaired renal function.
    Reutter FW; Vergin H; Sieber R; Ferber H
    J Antimicrob Chemother; 1979 Nov; 5(B):149-58. PubMed ID: 536339
    [No Abstract]   [Full Text] [Related]  

  • 37. Calculation of dosage regimens of antimicrobial drugs for the neonatal patient.
    Short CR; Clarke CR
    J Am Vet Med Assoc; 1984 Nov; 185(10):1088-93. PubMed ID: 6392235
    [No Abstract]   [Full Text] [Related]  

  • 38. Ciprofloxacin: pharmacokinetics and clinical experience.
    Eur J Clin Microbiol; 1986 Apr; 5(2):175-261. PubMed ID: 2941276
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on sulfamethoxazole-trimethoprim. Absorption, distribution, excretion and metabolism of trimethoprim in rat.
    Meshi T; Sato Y
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2079-90. PubMed ID: 4650364
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum level monitoring of antibacterial drugs. A review.
    Wenk M; Vozeh S; Follath F
    Clin Pharmacokinet; 1984; 9(6):475-92. PubMed ID: 6391780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.